StockClub

AKBA

AKBAAkebia Therapeutics, Inc.$ --
Akebia Therapeutics, Inc.

Akebia Therapeutics, Inc.

AKBA

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
54M USD
YoY -6.6%
Operating Income
-5M USD
YoY -134.7%
Net Income
-9M USD
YoY -248.1%
EPS
-0.03$
YoY -230.4%

Revenue

$53.5M
FY2024 Q2$76.3M
$76.3M
Q2
FY2024 Q3$113.7M
$113.7M
Q3
FY2024 Q4$160.2M
$160.2M
Q4
FY2025 Q1$57.3M
$57.3M
Q1
FY2025 Q2$119.8M
$119.8M
Q2
FY2025 Q3$178.6M
$178.6M
Q3
FY2025 Q4$236.2M
$236.2M
Q4
FY2026 Q1$53.5M
$53.5M
Q1
Actual
$-3.8M (-6.6%)

Net Income

$-9.1M
FY2024 Q2$-26.6M
$-26.6M
Q2
FY2024 Q3$-46.6M
$-46.6M
Q3
FY2024 Q4$-69.4M
$-69.4M
Q4
FY2025 Q1$6.1M
$6.1M
Q1
FY2025 Q2$6.4M
$6.4M
Q2
FY2025 Q3$6.9M
$6.9M
Q3
FY2025 Q4$-5.3M
$-5.3M
Q4
FY2026 Q1$-9.1M
$-9.1M
Q1
Actual
$-15.2M (-248.1%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$294.6M
Est:$288.5M
FY2020BEAT
$294.6M
FY2021BEAT
Actual:$211.7M
Est:$205.8M
FY2021BEAT
$211.7M
FY2022BEAT
Actual:$292.5M
Est:$284.8M
FY2022BEAT
$292.5M
FY2023BEAT
Actual:$194.6M
Est:$174.5M
FY2023BEAT
$194.6M
FY2024BEAT
Actual:$160.2M
Est:$151M
FY2024BEAT
$160.2M
FY2025BEAT
Actual:$236.2M
Est:$229.2M
FY2025BEAT
$236.2M

Analyst Estimates